2024. Real-World Experience of Upadacitinib Dosing Reduction in Patients With Moderate Atopic Dermatitis: A Case Series Study in Taiwan. Dermatology Practical & Conceptual. 14, 3 (Jul. 2024), e2024186. DOI:https://doi.org/10.5826/dpc.1403a186.